NCT06803641 The Effects of Mindfulness Practice With Tao Art (Love Peace Harmony Calligraphy and Song) on Well-being
| NCT ID | NCT06803641 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sha Research Foundation |
| Condition | Social Connectedness |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-04-05 |
| Primary Completion | 2030-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-04-05 with a primary completion date of 2030-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Effects of Mindfulness Practice with Tao Art ("Love Peace Harmony" Calligraphy and Song) on Well-being - Controlled Randomized Study The goal of this controlled randomized clinical study is to learn if a Tao Calligraphy Mindfulness Practice works to improve Well-being. The main questions it aims to answer are: * Does Tao Calligraphy Mindfulness practice improve these three aspects of well-being in adults: (1) Perceived Stress, (2) the Social Connectedness, and (3) Peace of Mind? * Will any improvement in the Perceived Stress Scale (PSS), the Social Connectedness Scale (SCS), and the Peace of Mind Scale (PMS) in adults be statistically significant? Investigators will compare the values of these three scales at the beginning of the mindfulness practices to their values at three months of practice and control groups. Participants will: * be randomized into practice and wait-list control groups * complete the set of three questionnaires upon entry into the study - (the baseline or zero time point; at the 3-months time point, and at the six-months time point * practice the mindfulness techniques with Tao Calligraphy and Tao Song for a minimum of thirty minutes daily
Eligibility Criteria
Inclusion criteria * Age 19 and over * Willingness and ability to comply with data collection requirements * Submission of required documentation before entering the study, including informed consent and consent to release of information * Willingness to allow their data to be used for research purposes and published as deemed fit (while conforming to all applicable privacy laws) by Sha Research Foundation * Willingness to practice the daily mindfulness practices for at least 30 minutes and follow the study protocol Exclusion criteria * Not meeting any of the inclusion criteria * Unwillingness to participate in data gathering * Unable to follow the practice regimen, including the daily individual mindfulness practices for at least 30 minutes * Pregnant or nursing. Participants who become pregnant during the study will be required to end their participation. * Serious mental disorders (e.g., schizophrenia) * There is no exclusion criteria placed upon potential subjects related to national origin, culture, ethnicity, race, sex, physical disability, sexual orientation, religion, or spiritual practices.
Contact & Investigator
Peter Hudoba De Badyn, MD, FRCS
PRINCIPAL INVESTIGATOR
Sha Research Foundation
Frequently Asked Questions
Who can join the NCT06803641 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Social Connectedness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06803641 currently recruiting?
Yes, NCT06803641 is actively recruiting participants. Contact the research team at sharesearchfoundation@yahoo.ca for enrollment information.
Where is the NCT06803641 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT06803641 clinical trial?
NCT06803641 is sponsored by Sha Research Foundation. The principal investigator is Peter Hudoba De Badyn, MD, FRCS at Sha Research Foundation. The trial plans to enroll 50 participants.